Radiology of Minimally Invasive Abdominal Surgery

Chapter 41 Radiology of Minimally Invasive Abdominal Surgery



The videos associated with this chapter are listed in the Video Contents and can be found on the accompanying DVDs and on Expertconsult.com.image


Over the past two decades, minimally invasive surgery has become the standard of care for a variety of abdominal and pelvic disorders. The increasing popularity of these procedures is related to reduced perioperative and postoperative morbidity, decreased postoperative pain, improved cosmetic results, and faster recovery. Multidetector computed tomography (MDCT), ultrasound, magnetic resonance imaging (MRI), magnetic resonance cholangiopancreatography (MRCP), and positron emission tomography combined with computed tomography (PET-CT) have assumed a primary role in the detection, characterization, and staging of a variety of benign and malignant disorders, many of which are amenable to minimally invasive surgery. These imaging modalities not only are key to the preoperative selection of patients for minimally invasive surgery but are also indispensable in detecting and in many cases treating postoperative complications. This chapter reviews the role of CT, MRI, and ultrasound in managing the patient undergoing the increasingly sophisticated process of minimally invasive abdominal procedures.



Imaging techniques



Multidetector Computed Tomography


Recent improvements in MDCT technology allow thinner collimation and faster scanning that provides multiphasic, high-resolution images of the abdomen and pelvis. These hardware developments, coupled with advances in three-dimensional imaging software and the availability of cheaper data storage capacity, have provided new opportunities for imaging a variety of pathologic processes. Isotropic imaging now is possible, providing two-dimensional multiplanar reformations, CT urography, CT colonography, CT enterography, and three-dimensional imaging formats, with minimal artifacts, and all derived from a single data acquisition. The patient can usually be scanned in less than 15 seconds, allowing for acquisition of thin-section images during multiple phases of the intravenous contrast bolus. This multiphasic evaluation permits high-resolution imaging of not only solid organs and hollow viscera but also the abdominal and pelvic vasculature. The data from these various series then can be reconstructed at thinner intervals and transferred to a workstation, in which multiplanar reformatted images, maximal-intensity projection images, and three-dimensional volume-rendered images can all be created.


MDCT is ideally suited for imaging the postoperative patient. Opacification of the gastrointestinal (GI) tract with positive contrast material is of critical importance for differentiation among bowel loops, intraperitoneal fluid collections, enlarged lymph nodes, and abscesses. For this purpose, at least 500 mL of dilute (2%) barium sulfate or iodinated compounds should be administered orally or through a nasogastric tube at least 1 hour before the examination. Water-soluble contrast media are preferable if there is any potential risk for intraperitoneal leakage from the GI lumen. Furthermore, water-soluble media tend to stimulate GI peristalsis and more readily opacify the distal small bowel and colon. Intravenous administration of iodinated contrast media is equally important in the detection of abscess and various vascular and parenchymal lesions in the postoperative abdomen. Other modifications, such as rectal contrast enema or scanning the patient in the decubitus or prone position, also are options when attempting to resolve a particular diagnostic dilemma.


The CT examination of the postoperative abdomen should extend from the dome of the diaphragm to the pelvic floor. This approach is warranted because many postoperative complications, particularly abscess and fluid collections, are often located at a site remote from the surgical field because of extension along preexisting anatomic pathways within the abdominal cavity.






Laparoscopic cholecystectomy


Since its introduction in the late 1980s, laparoscopic cholecystectomy has become the standard of care for removing the diseased gallbladder. The popularity of this procedure has advanced the popularity of minimally invasive techniques in many other abdominal and pelvic operations.



Preoperative Assessment of Gallstones


Ultrasound is the gold standard for the noninvasive diagnosis of cholelithiasis, with an accuracy of more than 96%. A sonographic diagnosis of cholelithiasis must fulfill three major criteria: (1) an echogenic focus, (2) acoustic shadowing from the focus, and (3) gravitational dependence of the focus. Confidence in the diagnosis is increased if a 5-mm or larger defect meets all three criteria. Stones smaller than 2 to 3 mm may be difficult to visualize. Small stones, however, are usually multiple, which assists in their detection.


The CT appearance of gallstones is variable, depending on their composition, the pattern of calcification, and the presence of lamellation, fissuring, or gas. Stones with high cholesterol content are difficult to visualize because they are isodense with the surrounding bile. Well-calcified stones are readily detected on CT. Stones that are denser than bile may be seen because of a rim or nidus of calcification. The CT attenuation of gallstones correlates more closely with the cholesterol content of the stones than with the calcium content. On CT, gallstones can be simulated by the enhancing mucosa of a contracted gallbladder wall or neck, which often folds upon itself.


On MRI, most gallstones produce little or no signal because of the restricted motion of water and cholesterol molecules in the crystalline lattice of the stone. To optimize gallbladder and ductal stone visualization on MRI, T2-weighted imaging sequences are used that produce bright bile. MRI is superior to CT in detecting small calculi because of the inherent contrast between low-signal-intensity stones and high-signal-intensity bile.



Choledocholithiasis


Choledocholithiasis is found in 7% to 20% of patients undergoing cholecystectomy and in 2% to 4% of patients after cholecystectomy. These stones usually are asymptomatic unless they obstruct the common bile duct (CBD). Small calculi may intermittently cause colicky pain as they obstruct the ampulla of Vater, but they generally pass into the duodenum. Larger stones (between 5 and 10 mm) are difficult to pass and can result in intermittent long-term symptoms and sequelae, such as cholangitis and sepsis.


The detection of bile duct stones is easiest in the setting of biliary dilation. Unfortunately, biliary dilation is present in only 66% to 75% of patients with bile duct stones, so their detection may be difficult. Sonographically, a bile duct stone may appear as an echogenic focus within the fluid-filled duct that may cast an acoustic shadow. A ductal stone also may appear as an echogenic curved line so that only the anterior margin is visualized, with homogeneous echogenicity throughout the stone, or without acoustic shadowing. Adjacent duodenal and colonic gas can make it difficult to image the distal common bile duct. Because of these factors, sonography has a sensitivity of only 18% to 45% in the detection of choledocholithiasis.


As with gallstones, the CT appearance of CBD stones is variable, depending on their composition and pattern of calcification. High-attenuation stones can be seen easily within the duct lumen even in the absence of biliary dilation. Only 20% of CBD stones have a homogeneous high density. Other findings include a rim of high attenuation (which may be difficult to detect when impacted against the duct wall), soft tissue attenuation, and homogeneous near-water attenuation. CBD stones rarely may have sufficient cholesterol to appear lower in attenuation than surrounding bile. MDCT with coronal reformatted images has a sensitivity of 76% to 80% in the detection of bile duct stones.


On MRI, CBD stones appear as foci of low signal intensity surrounded by bright bile on T2-weighted sequences. Stones as small as 2 mm can be detected by this technique, which has a sensitivity of 81% to 100% and a specificity of 85% to 99%. MRCP is superior to CT and ultrasound in selecting which patient may benefit from preoperative ERCP. MRCP has been recommended in the patient with gallstones and a moderate to high suspicion of CBD stones, based on clinical, sonographic, and laboratory data. MRCP can rule out CBD stones in up to 48% of patients with a high preoperative probability of CBD stones.



Acute Cholecystitis


The patient with suspected acute cholecystitis should undergo imaging because 60% to 85% of patients with an unconfirmed diagnosis have other causes of right upper quadrant pain, including peptic ulcer disease, pancreatitis, hepatitis, appendicitis, hepatic congestion from right-sided heart failure, perihepatitis from pelvic inflammatory disease (Fitz-Hugh–Curtis syndrome), right lower lobe pneumonia, right-sided pyelonephritis, nephroureterolithiasis, and so forth. Furthermore, imaging can diagnose severe complications that require immediate surgery, such as emphysematous cholecystitis or perforation.


The patient with suspected acute cholecystitis should have an ultrasound as the initial imaging procedure. If the diagnosis is in doubt after the ultrasound, then hepatobiliary scintigraphy or a CT can be performed. MDCT often is performed initially in many cases because the diagnosis is unclear. CT also may be quite helpful in suspected emphysematous cholecystitis or gallbladder perforation. MRI usually is employed to exclude obstructing and nonobstructing biliary tract stones.


The sonographic findings of acute uncomplicated cholecystitis include gallstones that may be impacted in the cystic duct or gallbladder neck, mural thickening (>3 mm), a three-layered appearance of the gallbladder wall, hazy delineation of the gallbladder, localized pain with maximal tenderness elicited over the gallbladder (sonographic Murphy sign), pericholecystic fluid, and gallbladder distention. Gallstones and the sonographic Murphy sign are the most specific indicators of acute cholecystitis, with a positive predictive value of 92%. The sonographic Murphy sign may be difficult to elicit in obtunded patients and in those who have received pain medication. Of note, Murphy sign may be absent in patients with gangrenous cholecystitis.


The CT findings of acute cholecystitis include gallstones, mural thickening of the gallbladder, mural edema, pericholecystic fluid and inflammation, and transient increased enhancement of the liver parenchyma adjacent to the gallbladder due to hyperemia. As stated before, CT is less sensitive (75%) than ultrasound in the depiction of gallstones. Stones with significant calcification or the presence of gas in a noncalcified stone (the Mercedes Benz sign) are best seen with CT. The CT findings of acute cholecystitis have been divided into major and minor criteria; the former include calculi, mural thickening of the gallbladder, pericholecystic fluid, and subserosal edema, whereas the latter include gallbladder distention and sludge. The overall sensitivity, specificity, and accuracy of CT for the diagnosis of acute cholecystitis are 92%, 99%, and 94%.


MRI rivals ultrasound and CT in the depiction of acute cholecystitis. On postgadolinium T1-weighted images, the findings of acute cholecystitis include increased mural enhancement, mural thickening, and transient increased enhancement of the adjacent liver parenchyma. Findings found on T2-weighted images include gallstones, intramural abscess (appearing as a hyperintense foci in the gallbladder wall), and a thickened gallbladder wall.


Radionuclide cholescintigraphy with technetium-99m–labeled iminodiacetic acid analogs (also known as HIDA scan) was first introduced in the late 1970s. In this examination, hepatic parenchymal uptake of the tracer is observed within 1 minute, with peak activity occurring at 10 to 15 minutes. The bile ducts are usually visualized within 10 minutes, and the gallbladder should fill with isotope within 1 hour, if the cystic duct is patent. If the gallbladder is not identified, then delayed imaging (up to 4 hours after injection) should be performed. Prompt biliary excretion of the isotope without visualization of the gallbladder is the hallmark of acute cholecystitis. False-positive results may occur in patients with abnormal bile flow because of hepatic parenchymal disease or secondary to a prolonged fast with a distended, sludge-filled gallbladder. Delayed gallbladder filling also can be seen in the setting of chronic cholecystitis.



Normal Imaging Findings after Uncomplicated Laparoscopic Cholecystectomy


Occasionally, a patient who has undergone laparoscopic cholecystectomy may present postoperatively with pain, fever, leukocytosis, and jaundice. Such a patient requires additional imaging that may reveal certain and unexpected findings. Normal radiographic findings in this setting are described later.












Bile Leakage


Bile leakage is one of the most common complications of laparoscopic cholecystectomy. Most leaks occur from the cystic duct stump. Other causes include laceration, transection, or thermal injury of the CBD or an unrecognized anomalous duct. CT and ultrasound are the initial imaging studies performed in the postoperative patient with suspected bile leak or biliary sepsis. Although both studies are useful in detecting intra-abdominal fluid collections, neither can differentiate between lymphocele, hematoma, seroma, or biloma (Fig. 41-2). Cross-sectional imaging studies can show a fluid collection in the gallbladder fossa, but such imaging cannot determine whether there is active bile leakage. Hepatobiliary scintigraphy (Fig. 41-3A), ERCP, or percutaneous transhepatic cholangiography (PTC) can show an active bile leak and the site of leakage. MRI employing gadoxetate disodium (Eovist), a gadolinium-based agent that is excreted in the bile, also is effective in showing bile leakage (Fig. 41-3B).





Acute Biliary Obstruction and Bile Duct Injury


A bile duct injury typically manifests with biliary dilation (Fig. 41-4) or bile leakage. The site of injury is described according to the Bismuth classification. A Bismuth type 1 injury indicates a remaining (noninjured) common hepatic duct longer than 2 cm; a type 2 injury has a remaining common hepatic duct shorter than 2 cm; a type 3 injury is located at the confluence of the right and left hepatic ducts; a type 4 injury extends into the right and left hepatic ducts. Major ductal injury from laparoscopic cholecystectomy generally is high in the biliary system, and multiple ducts often are involved. Mechanisms of CBD injury include malpositioning of surgical clips, thermal injury from sealing and cauterizing instruments, sharp incision, and en bloc excision.





Hemorrhage


Hemorrhage after laparoscopic cholecystectomy (Fig. 41-5) may occur from the cystic artery stump or the right hepatic artery. Bleeding may be secondary to thermal or mechanical injury, as with bile duct injury, or from dislodged hemostatic clips. Bleeding also can occur at a trocar insertion site, from the omentum or abdominal wall. MDCT is the most effective method for detecting bleeding because it will show the hyperdense hemorrhage and may show a focus of active bleeding or a pseudoaneurysm on contrast-enhanced scans. Transcatheter arterial embolization or surgical hemostasis may be considered, particularly if extravasation of the intravenous contrast agent is seen.




Stay updated, free articles. Join our Telegram channel

Jul 20, 2016 | Posted by in GASTOINESTINAL SURGERY | Comments Off on Radiology of Minimally Invasive Abdominal Surgery

Full access? Get Clinical Tree

Get Clinical Tree app for offline access